Ram Ganapathi

Selective enhancement of vincristine cytotoxicity in multidrug-resistant tumor cells by dilantin (phenytoin)

A. Hercbergs, R. Ganapathi, A. Hercbergs, 1993, Cancer research.

Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis.

G. T. Budd, E. Hawk, G. Kelloff, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis.

G. Piazza, M. Nitert, J. Church, 1999, Advances in experimental medicine and biology.

Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.

R. Ganapathi, D. Grabowski, Ram Ganapathi, 1983, Cancer research.

Differential reduction by caffeine of adriamycin induced cell killing and cell cycle delays in Chinese hamster V79 cells.

G. Iliakis, R. Ganapathi, A. Yen, 1986, International journal of radiation oncology, biology, physics.

Modulation of vinblastine cytotoxicity by dilantin (phenytoin) or the protein phosphatase inhibitor okadaic acid involves the potentiation of anti-mitotic effects and induction of apoptosis in human tumour cells.

R. Bukowski, R. Ganapathi, D. Grabowski, 1996, British Journal of Cancer.

Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotype.

R. Ganapathi, D. Grabowski, N. Kamath, 1993, British Journal of Cancer.

Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of doxorubicin (adriamycin) in resistant P388 mouse leukemia cells.

R. Ganapathi, D. Grabowski, R. Valenzuela, 1984, European journal of cancer & clinical oncology.

Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance.

N. Ratliff, R. Ganapathi, D. Grabowski, 1988, British Journal of Cancer.